Richter, Egis shares drop on spending cuts in Hungary, Russia


Shares of Richter Gedeon Nyrt, eastern Europe's biggest drugmaker by market value, dropped Ft 2,650, or 5.8%, to 43,000 at 10:17 a.m. in Budapest. Egis Nyrt, which ranks No. 5 in the region, fell Ft 1,370, or 4.9%, to 26,455. Hungary yesterday unveiled a draft law that would force drugmakers to give a rebate to the state health insurer, just as Russia announced it was removing medicines such as Richter's hypertension treatment Normodipine from its reimbursement list. Richter said profit may drop as much as 7% next year if the Hungarian plan becomes law. “Historically, both Egis and Richter have been able to adjust to difficult circumstances,” said Vladimira Urbankova, an analyst at Erste Bank in Prague. “I do not see this is something they can't live with. This is just the initial reaction.” Richter also warned yesterday that revenue from Russia would decline by $25 million this year because Normodipine and some versions of Cavinton, a medicine that helps blood flow to the brain, were taken off the country's reimbursement list. Egis CFO László Marosffy declined to say yesterday how much his company might lose from the government's reform plans. Profit at the company, which gets almost 40% of its revenue from Hungary, may drop 20%, according to Péter Tordai, an analyst at KBC Groep NV. (Bloomberg)


Surplus of External Trade in Services at EUR 2.69 bln in Q3 Trade

Surplus of External Trade in Services at EUR 2.69 bln in Q3

MPs Approve Tax Changes Parliament

MPs Approve Tax Changes

Automotive Industry Experiences Best Q3 on Record Automotive

Automotive Industry Experiences Best Q3 on Record

Hard Rock Hotel Opens 'Star Chalet' for Winter Season Hotels

Hard Rock Hotel Opens 'Star Chalet' for Winter Season


Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.